September 2002

Volume 2 Issue 9

Editorial Staff

Clinical Editor
Bradley Knight, MD
Executive Editor
Laurie Gustafson
Managing Editor
Jodie Elrod
Production Manager
Alexa Flinn

Editorial Correspondence

Jodie Elrod, Managing Editor, EP Lab Digest
HMP Communications, 70 E. Swedesford Rd
Suite 100, Malvern PA 19355
Telephone: (800) 371-0791

Fax: (866) 488-8273
Cardiac resynchronization therapy requires placement of a pacing lead to activate the posterolateral left ventricle (LV) prior to its anticipated and delayed depolarization. Epicardial LV access has been achieved by placing pacing leads in coronary s…
Recently, the U.S. FDA approved MADIT II indications for the implantable cardioverter/defibrillator. Specifically, they find that it is an acceptable indication for implanting these devices in patients who have experienced myocardial infarction and w…
What is the size of your EP lab facility and number of staff members? What is the mix of credentials at your lab? The Electrophysiology Lab at Einstein Heart Institute has one dedicated electrophysiology lab and an AICD and pacemaker clinic. Our te…
Atrial fibrillation (AF) affects over 3.3 million Americans, and 5 million people worldwide. Patients with atrial fibrillation often have associated symptoms such as heart palpitations, fatigue, dizziness, shortness of breath, and/or pressure or disc…
Intractable ventricular tachyarrhythmias (IVTA) have been defined as frequent, recurrent and recalcitrant ventricular tachyarrhythmias and/or ventricular fibrillation (VF), which may result in significant symptoms potentially associated with hemodyna…
When did digital healthcare start to take off and become more prevalent? What has been your role in this? How and when did you get started in this business? We figured the Internet was particularly useful for finding information and was a good way t…
Biosense Webster, a Johnson & Johnson company, announced U.S. release of the first Dual Sensor 8 mm tip ablation catheters specifically designed for the treatment of atrial flutter. The NAVISTAR DS and CELSIUS DS catheters received marketing clea…